Showing results (101-110 of 471) with videos related to

Sort By:
Pageof 48
Life Sciences|January 1, 1993
Automatic quantitative evaluation of autoradiographic band films by computerized image analysisM Masseroli, A Messori, C Bendotti, et al.
Journal of Clinical Gastroenterology|December 1, 1996
Cost effectiveness of adjuvant intraportal chemotherapy in patients with colorectal cancerA Messori, L Bonistalli, M Costantini, et al.
BMJ (Clinical Research Ed.)|November 4, 2000
Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trialsA Messori, S Trippoli, M Vaiani, et al.
Clinical Drug Investigation|August 14, 2016
Effectiveness of Immunoglobulins for the Prevention of Systemic Infections : A Meta-Analysis of 8 Clinical Studies in Premature InfantsM Rinaldi, F Bardelli, R Rampazzo, et al.
Thrombosis and Haemostasis|August 28, 2002
Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiencyM Pinotti, G Marchetti, M Baroni, et al.
Journal of Medical Virology|June 1, 1988
Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentratesO Bartolomei Corsi, A Azzi, M Morfini, et al.
Transfusion|October 1, 1993
Prospective study of the evaluation of hepatitis C virus infectivity in a high-purity, solvent/detergent-treated factor VIII concentrate: parallel evaluation of other markers for lipid-enveloped and non-lipid-enveloped viruses. The Ad Hoc Study Group of the Fondazione dell'EmofiliaG Mariani, T Di Paolantonio, R Baklaya, et al.
The Knee|July 3, 2007
A modular total knee arthroplasty in haemophilic arthropathyM Innocenti, R Civinini, C Carulli, et al.
American Journal of Hematology|March 1, 1992
Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VIII concentratesA Azzi, S Ciappi, K Zakvrzewska, et al.
Journal of Thrombosis and Haemostasis : JTH|November 25, 2003
A multicenter pharmacokinetic study of the B-domain deleted recombinant factor VIII concentrate using different assays and standardsM Morfini, S Cinotti, A Bellatreccia, et al.
Pageof 48